Inhibikase Therapeutics
IKT
IKT
54 hedge funds and large institutions have $89M invested in Inhibikase Therapeutics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less capital invested
Capital invested by funds: $106M → $89M (-$17.3M)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$562K | |
| 2 | +$203K | |
| 3 | +$178K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$158K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$130K |
Top Sellers
| 1 | -$547K | |
| 2 | -$70.7K | |
| 3 | -$62.3K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$60.6K |
| 5 |
Barclays
London,
United Kingdom
|
-$40K |
